The Acute Effects of Onnit Alpha Brain on Cognition and Mood States
Part of paid clinical trials in Tampa, Florida.
- Sponsor
- Applied Science & Performance Institute
- Study ID
- NCT07495592
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cognitive
- Executive Function (Cognition)
- Fatigue
- Mood and Cognitive Performance
- Sleep Deprivation
Eligibility Criteria
- Sex
- ALL
- Age
- 20 Years - 59 Years
- Healthy Volunteers
- Accepted
Interventions
- Alpha Brain proprietary cognitive dietary supplement — DIETARY_SUPPLEMENTAlpha Brain is a proprietary investigational dietary supplement. The formulation contains a combination of dietary ingredients commonly used in cognitive supplement mixes.
- Alpha Brain 2.0 proprietary cognitive dietary supplement — DIETARY_SUPPLEMENTAlpha Brain 2.0 is a proprietary investigational dietary supplement. The formulation contains a combination of dietary ingredients commonly used in cognitive supplements and will be evaluated under double-blind conditions in a randomized, placebo-controlled crossover study.
- Controlled Placebo — DIETARY_SUPPLEMENTThe placebo consists of an inactive placebo mix administered orally as two capsules.
Study Details
The purpose of this randomized, double-blind, placebo-controlled crossover study is to evaluate the efficacy of the acute effects of an investigational supplement (Alpha Brain or Alpha Brain 2.0) on improving cognitive performance, vigilance, and subjective mood in healthy adults compared to placebo during a period of acute sleep deprivation under conditions of controlled sleep deprivation.
Key Dates
- Start date
- Apr 16, 2026
- Status verified
- Mar 2026
- Primary completion
- Aug 1, 2026
- Completion
- Aug 15, 2026
Study Design
- Enrollment
- 34 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Experimental: Alpha BrainAlpha Brain investigational dietary supplement administered as two oral capsules with water
- Active Comparator: Alpha Brain 2.0Alpha Brain 2.0 investigational dietary supplement administered as two oral capsules with water
- Placebo Comparator: Control TreatmentInactive/inert placebo capsules administered as two oral capsules with water
Primary Outcome Measure
Psychomotor Vigilance Test [ Time Frame: Subjects will complete this on each of the three visits at baseline, and then repeated at 60 minutes, 120 minutes, and 180 minutes post supplementation. ]
Central Contacts
- Eric Sikorski, PhD8138678888
- Gabe Wilson, PhD8138678888
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Applied Science Performance Institute | Tampa | Florida | 33634 |
Find similar trials in Tampa, FL
Related Studies
- Exercise to ReGain Stamina and Energy (The EXERGISE Study)Recruiting · University of Florida · Gainesville, Florida
- Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic InsomniaPHASE1 · Not Yet Recruiting · Nyree Penn · Aventura, Florida
- Randomized, Open-label, Safety Study of Subcutaneous and Intramuscular Injections of Niagen® PlusPHASE1 · Recruiting · ChromaDex, Inc. · Miami, Florida
- Transcranial Electrical Stimulation (TES) at Slow Oscillation (SO) Frequency During NREM SleepRecruiting · U.S. Army Medical Research and Development Command · Bethesda, Maryland